You Own Wall Street › Companies › Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated shareholder proposals
What shareholders asked Vertex Pharmaceuticals Incorporated to do, and how the funds inside American retirement plans voted on it — with the filing behind every vote.
14 May 2025 · put on the ballot by shareholder · Executive pay
Should shareholders get a vote before Vertex Pharmaceuticals Incorporated pays a departing executive?
Shareholders asked the company to seek shareholder approval for any severance package to a senior executive above a set multiple of salary and bonus — so that very large exit payments cannot be agreed by the board alone.
“Shareholder proposal, if properly presented at the meeting, regarding excessive golden parachutes.”
1 of 4 funds we track voted for it.
| Fund | Vote | Shares voted |
|---|---|---|
| Growth Fund of America | AGAINST | 11,339,049 |
| New Perspective Fund | AGAINST | 4,024,523 |
| Fidelity Contrafund | AGAINST | 2,942,898 |
| Janus Henderson Forty Portfolio | FOR | 34,227 |
The same proposal was put to Pfizer, Johnson & Johnson, Citigroup, Capital One Financial, GE Aerospace, PACCAR.
Vote these yourself
Say how you would have voted, then see what your own fund did. Open the ballot deck →